Search Page

1

Cite

Share

Optimizing molecular surveillance of mumps genotype G viruses.

Bodewes R, van Rooijen K, Cremer J, Veldhuijzen IK, van Binnendijk R. Bodewes R, et al. Among authors: veldhuijzen ik. Infect Genet Evol. 2019 Apr;69:230-234. doi: 10.1016/j.meegid.2019.02.005. Epub 2019 Feb 7. Infect Genet Evol. 2019. PMID: 30738791

Cite

Share

2

Cite

Share

Molecular epidemiology of mumps viruses in the Netherlands, 2017-2019.

Bodewes R, Reijnen L, Kerkhof J, Cremer J, Schmitz D, van Binnendijk R, Veldhuijzen IK. Bodewes R, et al. Among authors: veldhuijzen ik. PLoS One. 2020 Sep 14;15(9):e0233143. doi: 10.1371/journal.pone.0233143. eCollection 2020. PLoS One. 2020. PMID: 32925979 Free PMC article.

Cite

Share

3

Cite

Share

Oral fluid: Non-invasive alternative for parvovirus B19 diagnosis?

Bodewes R, Kerkhof J, Cremer J, Gijselaar DB, Voordouw BCG, Veldhuijzen IK, Schipper M, van Binnendijk R. Bodewes R, et al. Among authors: veldhuijzen ik. J Clin Virol. 2019 Aug;117:5-10. doi: 10.1016/j.jcv.2019.05.008. Epub 2019 May 19. J Clin Virol. 2019. PMID: 31128380 Free article.

Cite

Share

4

Cite

Share

[No scientific lower threshold for compulsory vaccination].

Klinkenberg D, Veldhuijzen IK, Ruijs WLM, de Melker HE, Wallinga J, van den Hof S, van Dissel JT, van Vliet JA. Klinkenberg D, et al. Among authors: veldhuijzen ik. Ned Tijdschr Geneeskd. 2020 May 7;164:D4556. Ned Tijdschr Geneeskd. 2020. PMID: 32395948 Dutch.

Cite

Share

5

Cite

Share

A Third Dose of Measles-Mumps-Rubella Vaccine to Improve Immunity Against Mumps in Young Adults.

Kaaijk P, Wijmenga-Monsuur AJ, van Houten MA, Veldhuijzen IK, Ten Hulscher HI, Kerkhof J, van der Klis FR, van Binnendijk RS. Kaaijk P, et al. Among authors: veldhuijzen ik. J Infect Dis. 2020 Mar 2;221(6):902-909. doi: 10.1093/infdis/jiz188. J Infect Dis. 2020. PMID: 31112277

Cite

Share

6

Cite

Share

Hepatitis B/C in the countries of the EU/EEA: a systematic review of the prevalence among at-risk groups.

Falla AM, Hofstraat SHI, Duffell E, Hahné SJM, Tavoschi L, Veldhuijzen IK. Falla AM, et al. Among authors: veldhuijzen ik. BMC Infect Dis. 2018 Feb 12;18(1):79. doi: 10.1186/s12879-018-2988-x. BMC Infect Dis. 2018. PMID: 29433454 Free PMC article. Review.

Cite

Share

7

Cite

Share

Hepatitis B and C testing strategies in healthcare and community settings in the EU/EEA: A systematic review.

Mason LMK, Veldhuijzen IK, Duffell E, van Ahee A, Bunge EM, Amato-Gauci AJ, Tavoschi L. Mason LMK, et al. Among authors: veldhuijzen ik. J Viral Hepat. 2019 Dec;26(12):1431-1453. doi: 10.1111/jvh.13182. Epub 2019 Aug 16. J Viral Hepat. 2019. PMID: 31332919 Free PMC article.

Cite

Share

8

Cite

Share

Chronic hepatitis B and C infections in the Netherlands: estimated prevalence in risk groups and the general population.

Koopsen J, van Steenbergen JE, Richardus JH, Prins M, Op de Coul ELM, Croes EA, Heil J, Zuure FR, Veldhuijzen IK. Koopsen J, et al. Among authors: veldhuijzen ik. Epidemiol Infect. 2019 Jan;147:e147. doi: 10.1017/S0950268819000359. Epidemiol Infect. 2019. PMID: 30869044 Free PMC article.

Cite

Share

9

Cite

Share

Seroepidemiology of Measles, Mumps and Rubella on Bonaire, St. Eustatius and Saba: The First Population-Based Serosurveillance Study in Caribbean Netherlands.

Vos RA, Mollema L, van Binnendijk R, Veldhuijzen IK, Smits G, Janga-Jansen AVA, Baboe-Kalpoe S, Hulshof K, van der Klis FRM, Melker HE. Vos RA, et al. Among authors: veldhuijzen ik. Vaccines (Basel). 2019 Oct 1;7(4):137. doi: 10.3390/vaccines7040137. Vaccines (Basel). 2019. PMID: 31581508 Free PMC article.

Cite

Share

10

Cite

Share

Hepatitis B and C prevalence and incidence in key population groups with multiple risk factors in the EU/EEA: a systematic review.

Mason LM, Duffell E, Veldhuijzen IK, Petriti U, Bunge EM, Tavoschi L. Mason LM, et al. Among authors: veldhuijzen ik. Euro Surveill. 2019 Jul;24(30):1800614. doi: 10.2807/1560-7917.ES.2019.24.30.1800614. Euro Surveill. 2019. PMID: 31362808 Free PMC article.

Cite

Share